Reinduction of an Anti-EGFR-based First-line Regimen in Patients with RAS Wild-type Metastatic Colorectal Cancer Enrolled in the Valentino Study.
Fucà G, Raimondi A, Prisciandaro M, Lonardi S, Cremolini C, Ratti M, Clavarezza M, Murialdo R, Sartore-Bianchi A, Smiroldo V, Berenato R, Racca P, Bergamo F, Corallo S, Di Bartolomeo M, de Braud F, Morano F, Pietrantonio F.
Fucà G, et al. Among authors: di bartolomeo m.
Oncologist. 2022 Feb 3;27(1):e29-e36. doi: 10.1093/oncolo/oyab012.
Oncologist. 2022.
PMID: 35305093
Free PMC article.